Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Prospective Observational Epidemiologic Study of Maraviroc's Safety
Prospective Observational Epidemiologic Study of Maraviroc's Safety

NCT00665561

CompletedN/A

Sponsor: ViiV Healthcare

Conditions: Human Immunodeficiency Virus

Interventions: Maraviroc along with an optimized background antiretroviral drug regimen, Optimized background antiretroviral drug regimen without maraviroc

Countries: United States, Belgium, Brazil, Canada, France, Germany, Greece, Italy

The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Treatment experienced, HIV-1 infected patients
* 18 years or older
* Receive an approved assay for determination of HIV-1 tropism

Exclusion Criteria:

* Pregnant or lactating
* Using CCR5 inhibitor other than maraviroc
Locations (269)
  • Hobson City, Alabama, United States
  • Huntsville, Alabama, United States
  • Huntsville, Alabama, United States
  • Bakersfield, California, United States
  • Burbank, California, United States
  • Fountain Valley, California, United States
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Oakland, California, United States
  • Orange, California, United States
  • Palm Desert, California, United States
  • Palo Alto, California, United States
  • Sacramento, California, United States
  • San Francisco, California, United States
  • San Francisco, California, United States
  • Stanford, California, United States
  • Victorville, California, United States
  • Denver, Colorado, United States
  • Denver, Colorado, United States
  • Lafayette, Colorado, United States
  • New Haven, Connecticut, United States
  • New Haven, Connecticut, United States
  • New Haven, Connecticut, United States
  • Norwalk, Connecticut, United States
  • Washington D.C., District of Columbia, United States
  • Washington D.C., District of Columbia, United States
  • Washington D.C., District of Columbia, United States
  • Washington D.C., District of Columbia, United States
  • + 239 more on CT.gov